During the last session, Clover Health Investments Corp (NASDAQ:CLOV)’s traded shares were 10.15 million, with the beta value of the company hitting 2.01. At the end of the trading day, the stock’s price was $4.68, reflecting an intraday gain of 8.58% or $0.37. The 52-week high for the CLOV share is $4.71, that puts it down -0.64 from that peak though still a striking 86.97% gain since the share price plummeted to a 52-week low of $0.61. The company’s market capitalization is $2.35B, and the average intraday trading volume over the past 10 days was 7.51 million shares, and the average trade volume was 6.02 million shares over the past three months.
Clover Health Investments Corp (CLOV) received a consensus recommendation of Hold from analysts. That translates to a mean rating of 2.00. CLOV has a Sell rating from 0 analyst(s) out of 1 analysts who have looked at this stock. 1 analyst(s) recommend to Hold the stock while 0 suggest Overweight, and 0 recommend a Buy rating for it.
Clover Health Investments Corp (NASDAQ:CLOV) trade information
Clover Health Investments Corp (CLOV) registered a 8.58% upside in the last session and has traded in the green over the past 5 sessions. The stock spiked 8.58% in intraday trading to $4.68, hitting a weekly high. The stock’s 5-day price performance is 17.59%, and it has moved by 46.71% in 30 days. Based on these gigs, the overall price performance for the year is 395.29%. The short interest in Clover Health Investments Corp (NASDAQ:CLOV) is 15.96 million shares and it means that shorts have 3.48 day(s) to cover.
The consensus price target of analysts on Wall Street is $4.25, which implies a decrease of -10.12% to the stock’s current value. The extremes of the forecast give a target low and a target high price of $2.5 and $6 respectively. As a result, CLOV is trading at a discount of -28.21% off the target high and 46.58% off the low.
Clover Health Investments Corp (CLOV) estimates and forecasts
Statistics show that Clover Health Investments Corp has outperformed its competitors in share price, compared to the industry in which it operates. Clover Health Investments Corp (CLOV) shares have gone up 181.93% during the last six months, with a year-to-date growth rate more than the industry average at 70.73% against 24.70.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -585.84%. While earnings are projected to return 73.20% in 2025.
CLOV Dividends
Clover Health Investments Corp is due to release its next quarterly earnings in February. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Clover Health Investments Corp (NASDAQ:CLOV)’s Major holders
Clover Health Investments Corp insiders own 5.24% of total outstanding shares while institutional holders control 20.22%, with the float percentage being 21.34%. VANGUARD GROUP INC is the largest shareholder of the company, while 189.0 institutions own stock in it. As of 2024-06-30, the company held over 17.35 million shares (or 3.5662% of all shares), a total value of $21.33 million in shares.
The next largest institutional holding, with 11.27 million shares, is of RENAISSANCE TECHNOLOGIES LLC’s that is approximately 2.3176% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $13.86 million.
Also, the Mutual Funds coming in first place with the largest holdings of Clover Health Investments Corp (CLOV) shares are Vanguard Total Stock Market Index Fund and Vanguard Extended Market Index Fund . Data provided on Sep 30, 2024 indicates that Vanguard Total Stock Market Index Fund owns about 10.94 shares. This amounts to just over 2.65 percent of the company’s overall shares, with a $51.2 million market value. The same data shows that the other fund manager holds slightly less at 6.07, or about 1.47% of the stock, which is worth about $28.42 million.
